Antiviral treatment for hepatitis B virus recurrence following liver transplantation

Authors
Sanghoon LeeChoon Hyuck D. KwonHyung Hwan MoonTae-Seok KimYoungnam RohSanghyun SongMilljae ShinJong Man KimJae Berm ParkSung Joo KimJae-Won JohSuk-Koo Lee
Department
Dept. of Surgery (외과학)
Issue Date
2013
Citation
Clinical Transplantation, Vol.27(5) : E597-E604, 2013
ISSN
0902-0063
Abstract
The purpose of this study was to identify the factors associated with the recurrence of hepatitis B virus (HBV) following liver transplantation (LT) for HBV-related disease and to recognize the outcome of treatment for HBV recurrence with oral nucleos(t)ide analogues. Six hundred and sixty-seven LTs were performed for HBsAgpositive adult patients in our institute from 1996 to 2010. HBV prophylaxis was performed by hepatitis B immunoglobulin (HBIG) monotherapy or HBIG and entecavir combination therapy. There were 63 cases (11.4%) of HBV recurrences during a median follow-up of 51 months. The median time to HBV recurrence was 22 months. A preoperative HBV DNA load of more than 105 IU/mL, HBIG monotherapy, and hepatocellular carcinoma in the explant liver were independent risk factors for HBV recurrence following LT in multivariate analysis. Patient survival at 10 yr was 54.2% for HBVrecurrent patients. Among patients with HBV recurrence, HBsAg seroclearance was achieved in 13 patients (20.6%), but HBsAg seroclearance did not affect survival in these patients after the recurrence of HBV (p = 0.28). The recurrence of HBV led to graft failure in six cases. HBV recurrence should be prevented by strict management of pre-transplant HBV viremia and an effective post-transplant HBV prophylaxis.
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/35526
Appears in Collections:
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Surgery (외과학)
Keimyung Author(s)
김태석
Full Text
http://dx.doi.org.proxy.dsmc.or.kr/10.1111/ctr.12212
File in this Item
 사서에게 요청하기
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE